{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:05:33Z","timestamp":1790175933085,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T00:00:00Z","timestamp":1393977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00213-014-3509-2","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T11:27:06Z","timestamp":1393932426000},"page":"3695-3706","source":"Crossref","is-referenced-by-count":39,"title":["Effects of the nicotinic \u03b17 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats"],"prefix":"10.1007","volume":"231","author":[{"given":"Patrick M.","family":"Callahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Alvin V.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Tehim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"key":"3509_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/oxfordjournals.schbul.a033320","volume":"24","author":"LE Adler","year":"1998","unstructured":"Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K et al (1998) Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24:189\u2013202","journal-title":"Schizophr Bull"},{"key":"3509_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbr.2005.09.005","volume":"167","author":"JA Ainge","year":"2006","unstructured":"Ainge JA, Heron-Maxwell C, Theofilas P, Wright P, de Hoz L, Wood ER (2006) The role of the hippocampus in object recognition in rats: examination of the influence of task parameters and lesion size. Behav Brain Res 167:183\u2013195","journal-title":"Behav Brain Res"},{"key":"3509_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1523\/JNEUROSCI.16-01-00019.1996","volume":"16","author":"S Akbarian","year":"1996","unstructured":"Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP et al (1996) Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16:19\u201330","journal-title":"J Neurosci"},{"key":"3509_CR4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ajp.156.9.1358","volume":"156","author":"A Aleman","year":"1999","unstructured":"Aleman A, Hijmann R, de Haan EH, Kahn RS (1999) Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 156:1358\u20131366","journal-title":"Am J Psychiatry"},{"key":"3509_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0006-8993(94)01449-R","volume":"674","author":"GW Arendash","year":"1995","unstructured":"Arendash GW, Sengstock GJ, Sanberg PR, Kem WR (1995) Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252\u2013259","journal-title":"Brain Res"},{"key":"3509_CR6","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1523\/JNEUROSCI.5289-06.2007","volume":"27","author":"GRI Barker","year":"2007","unstructured":"Barker GRI, Bird F, Alexander V, Warburton EC (2007) Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 27:2948\u20132957","journal-title":"J Neurosci"},{"key":"3509_CR7","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/sj.npp.1301604","volume":"33","author":"M Beneyto","year":"2008","unstructured":"Beneyto M, Meador-Woodruff JH (2008) Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 33:2175\u20132186","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1124\/jpet.110.167213","volume":"334","author":"RS Bitner","year":"2010","unstructured":"Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S et al (2010) In vivo pharmacological characterization of a novel selective \u03b17 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer\u2019s disease. J Pharmacol Exp Ther 334:875\u2013886","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00213-004-1848-0","volume":"174","author":"DL Braff","year":"2004","unstructured":"Braff DL, Light GA (2004) Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology 174:75\u201385","journal-title":"Psychopharmacology"},{"key":"3509_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234\u2013258","journal-title":"Psychopharmacology"},{"key":"3509_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0091-3057(96)00354-1","volume":"57","author":"CA Briggs","year":"1997","unstructured":"Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campell JE et al (1997) Functional characterization of the novel neuronal nicotinic receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav 57:231\u2013241","journal-title":"Pharmacol Biochem Behav"},{"key":"3509_CR12","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bcp.2009.06.102","volume":"78","author":"JJ Buccafusco","year":"2009","unstructured":"Buccafusco JJ, Terry AV Jr (2009) A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochem Pharmacol 78:852\u2013862","journal-title":"Biochem Pharmacol"},{"key":"3509_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1101\/lm.251906","volume":"13","author":"EA Buffalo","year":"2006","unstructured":"Buffalo EA, Bellgowan PS, Martin A (2006) Distinct roles for medial temporal lobe structure in memory for objects and their locations. Learn Mem 13:638\u2013643","journal-title":"Learn Mem"},{"key":"3509_CR14","first-page":"S198","volume":"32","author":"PM Callahan","year":"2006","unstructured":"Callahan PM, Wang S, Xie W, Dragan S, Sun S, Michael T et al (2006) Pharmacological characterization of MEM 3454, a novel nicotinic alpha7 receptor partial agonist: therapeutic potential for the cognitive deficits associated with Alzheimer\u2019s disease and schizophrenia. Neuropsychopharmacology 32:S198","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuropharm.2012.10.019","volume":"67","author":"PM Callahan","year":"2013","unstructured":"Callahan PM, Hutchings EJ, Kille NJ, Chapman JM, Terry AV Jr (2013) Positive allosteric modulator of \u03b17 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates. Neuropharmacology 67:201\u2013212","journal-title":"Neuropharmacology"},{"key":"3509_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuropharm.2012.05.003","volume":"64","author":"CE Cannon","year":"2013","unstructured":"Cannon CE, Puri V, Vivian JA, Egbertson MS, Eddins D, Uslaner JM (2013) The nicotinic \u03b17 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys. Neuropharmacology 64:191\u2013196","journal-title":"Neuropharmacology"},{"key":"3509_CR17","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.20-23-08853.2000","volume":"20","author":"RE Clark","year":"2000","unstructured":"Clark RE, Zola SM, Squire LR (2000) Impaired recognition memory in rats after damage to the hippocampus. J Neurosci 20:8853\u20138860","journal-title":"J Neurosci"},{"key":"3509_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbr.2004.05.016","volume":"156","author":"MN Lima De","year":"2005","unstructured":"De Lima MN, Laranja DC, Bromberg E, Roesler R, Schroeder N (2005) Pre- or post-training administration of the NMDA receptor blocker Mk-801 impairs object recognition memory in rats. Behav Brain Res 156:139\u2013143","journal-title":"Behav Brain Res"},{"key":"3509_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1124\/jpet.108.146514","volume":"328","author":"J Dunlop","year":"2009","unstructured":"Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, Jow F et al (2009) Old and new pharmacology: positive allosteric modulation of the \u03b17 nicotinic acetylcholine receptor by the 5-hydroxyptamine (2B\/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b\u2032]di pyrrole-1(2H)-carboxamide). J Pharmacol Exp Ther 328:766\u2013776","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","volume":"31","author":"A Ennaceur","year":"1988","unstructured":"Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47\u201359","journal-title":"Behav Brain Res"},{"key":"3509_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1176\/appi.neuropsych.20.2.227","volume":"20","author":"C Exner","year":"2008","unstructured":"Exner C, Nehrkorn B, Martin V, Huber M, Shiratori K, Rief W (2008) Sex-dependent hippocampal volume reductions in schizophrenia relate to episodic memory deficits. J Neuropsychiatry Clin Neurosci 20:227\u2013230","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3509_CR22","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1523\/JNEUROSCI.21-20-07993.2001","volume":"21","author":"R Fabian-Fine","year":"2001","unstructured":"Fabian-Fine R, Skehel P, Errington ML, Davies HA, Sher E, Stewart MG, Fine A (2001) Ultrastructual distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 21:7993\u20138003","journal-title":"J Neurosci"},{"key":"3509_CR23","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1176\/appi.ajp.2008.07071135","volume":"165","author":"R Freedman","year":"2008","unstructured":"Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L et al (2008) Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 165:1040\u20131047","journal-title":"Am J Psychiatry"},{"key":"3509_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.schres.2006.05.022","volume":"87","author":"TP George","year":"2006","unstructured":"George TP, Termine A, Sacco KA, Allen TM, Reutenauer E et al (2006) A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res 87:307\u2013315","journal-title":"Schizophr Res"},{"key":"3509_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/schbul\/13.4.643","volume":"13","author":"MA Geyer","year":"1987","unstructured":"Geyer MA, Braff DL (1987) Startle habituation and sensorimotor gating in schizophrenia and related animals models. Schizophr Bull 13:643\u2013668","journal-title":"Schizophr Bull"},{"key":"3509_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117\u2013154","journal-title":"Psychopharmacology"},{"key":"3509_CR27","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1021\/jm901692q","volume":"53","author":"C Ghiron","year":"2010","unstructured":"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C et al (2010) Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl) pyridine-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625\/WYE-103914). J Med Chem 53:4379\u20134389","journal-title":"J Med Chem"},{"key":"3509_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0920-9964(97)00079-0","volume":"27","author":"DC Goff","year":"1997","unstructured":"Goff DC, Wine L (1997) Glutamate in schizophrenia: clinical and research implications. Schizophr Res 27:157\u2013168","journal-title":"Schizophr Res"},{"key":"3509_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0006-3223(00)01027-1","volume":"49","author":"MF Green","year":"2001","unstructured":"Green MF, Braff DL (2001) Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biol Psychiatry 49:374\u2013384","journal-title":"Biol Psychiatry"},{"key":"3509_CR30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1124\/jpet.104.076968","volume":"312","author":"M Hajos","year":"2005","unstructured":"Hajos M, Hurst RS, Hoffmann WE, Krause M, Wall TM, Higdon NR, Groppi VE (2005) The selective \u03b17 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-azabiyclo[2.2.2]oct-3-yl]-4-chlorbenzamide hydrochloride] enhances GABergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized. J Pharmacol Exp Ther 312:1213\u20131222","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-005-0142-0","volume":"183","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Iyo M, Freedman R, Stevens KE (2005) Tropisetron improves deficient inhibitory auditory processing in DBA\/2 mice: role of alpha 7 nicotinic acetylcholine receptors. Psychopharmacology 183:13\u201319","journal-title":"Psychopharmacology"},{"key":"3509_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejphar.2006.09.055","volume":"553","author":"K Hashimoto","year":"2006","unstructured":"Hashimoto K, Fujita Y, Ishima T, Hagiwara H, Iyo M (2006) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of \u03b17 nicotinic receptors. Eur J Pharmacol 553:191\u2013195","journal-title":"Eur J Pharmacol"},{"key":"3509_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biopsych.2007.04.034","volume":"63","author":"K Hashimoto","year":"2008","unstructured":"Hashimoto K, Ishima T, Fujita Y, Matsuo M, Kobahis T et al (2008) Phencyclidine-induced cognitive defects in mice are improved by subsequent subchronic administration of the novel selective \u03b17 nicotinic receptor agonist SSR180711. Biol Psychiatry 63:92\u201397","journal-title":"Biol Psychiatry"},{"key":"3509_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bcp.2009.05.030","volume":"78","author":"TA Hauser","year":"2009","unstructured":"Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, Hesse RA et al (2009) TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol 78:803\u2013812","journal-title":"Biochem Pharmacol"},{"key":"3509_CR35","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/j.jalz.2009.07.147","volume":"5","author":"D Hilt","year":"2009","unstructured":"Hilt D, Gawryl M, Koenig G (2009) EVP-6124: safety, tolerability and cognitive effects of a novel A7 nicotinic receptor agonist in Alzheimer\u2019s disease patients on stable donepezil or rivastigmine therapy. Alzheimers Dement 5:e32","journal-title":"Alzheimers Dement"},{"key":"3509_CR36","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/sj.npp.1301601","volume":"33","author":"LE Hong","year":"2008","unstructured":"Hong LE, Wonodi I, Lewis J, Thaker GK (2008) Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology 33:2167\u20132174","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR37","first-page":"S184","volume":"37","author":"M Huang","year":"2011","unstructured":"Huang M, Meltzer H, Felix A, Panos J, Van Goethem N, Bertrand S et al (2011) EVP-6124, an alpha-7 nicotinic receptor partial agonist enhances cognition and efflux of dopamine, acetylcholine and glutamate in rat cortex at low brain concentrations. Neuropsychopharmacology 37:S184","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","volume":"137","author":"R Hurst","year":"2013","unstructured":"Hurst R, Rollema H, Bertrand D (2013) Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther 137:22\u201354","journal-title":"Pharmacol Ther"},{"key":"3509_CR39","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","volume":"27","author":"S Kapur","year":"2003","unstructured":"Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsycholopharmacol Biol Psychiatry 27:1081\u20131090","journal-title":"Prog Neuropsycholopharmacol Biol Psychiatry"},{"key":"3509_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0166-4328(00)00211-4","volume":"113","author":"WR Kem","year":"2000","unstructured":"Kem WR (2000) The brain \u03b17 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer\u2019s disease: studies with DMXBA (GTS-21). Behav Brain Res 113:169\u2013181","journal-title":"Behav Brain Res"},{"key":"3509_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/sj.npp.1300028","volume":"28","author":"H Kitagawa","year":"2003","unstructured":"Kitagawa H, Takenouchi T, Azuma R, Wesnes KA, Kramer WG, Clody DE, Burnett AL (2003) Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28:542\u2013551","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2010.07.037","volume":"1353","author":"S Kohnomi","year":"2010","unstructured":"Kohnomi S, Suemaru K, Goda M, Choshi T et al (2010) Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the \u03b17 nicotinic acetylcholine receptor in Wistar rats. Brain Res 1353:152\u2013158","journal-title":"Brain Res"},{"key":"3509_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.schres.2004.12.016","volume":"76","author":"K Koike","year":"2005","unstructured":"Koike K, Hashimoto K, Takai N, Shimizu E, Komatsu N, Watanabe H et al (2005) Tropisetron improves deficits in auditory P50 suppression in schizophrenia. Schizophr Res 76:67\u201372","journal-title":"Schizophr Res"},{"key":"3509_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF01248936","volume":"77","author":"J Kornhuber","year":"1989","unstructured":"Kornhuber J, Mack-Burkhardt F, Riederer P, Hebenstreit GF, Reynolds GP et al (1989) [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm 77:231\u2013236","journal-title":"J Neural Transm"},{"key":"3509_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hup.286","volume":"16","author":"V Kumari","year":"2001","unstructured":"Kumari V, Soni W, Sharma T (2001) Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 16:321\u2013326","journal-title":"Hum Psychopharmacol"},{"key":"3509_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0925-4927(02)00123-3","volume":"122","author":"V Kumari","year":"2003","unstructured":"Kumari V, Gray JA, Geyer MA, Ffytche D, Soni W, Mitterschiffthaler MT et al (2003) Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 122:99\u2013113","journal-title":"Psychiatry Res"},{"key":"3509_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00213-011-2377-2","volume":"219","author":"JA Larrauri","year":"2012","unstructured":"Larrauri JA, Levin ED (2012) The \u03b12-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine and dizocilpine in rats. Psychopharmacology 219:99\u2013108","journal-title":"Psychopharmacology"},{"key":"3509_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","volume":"25","author":"AC Lathi","year":"2001","unstructured":"Lathi AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455\u2013467","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.pbb.2007.02.005","volume":"86","author":"ED Levin","year":"2007","unstructured":"Levin ED, Caldwell DP, Perraut C (2007) Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol Biochem Behav 86:597\u2013605","journal-title":"Pharmacol Biochem Behav"},{"key":"3509_CR50","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/npp.2012.259","volume":"38","author":"JA Lieberman","year":"2013","unstructured":"Lieberman JA, Dunbar G, Segreti AC, Girgis RR, Seoane F, Beaver JS et al (2013) A randomized exploratory trial of an alpha-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology 38:968\u2013975","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00213-011-2536-5","volume":"220","author":"L Lyon","year":"2012","unstructured":"Lyon L, Saksida LM, Bussey TJ (2012) Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology 220:647\u2013672","journal-title":"Psychopharmacology"},{"key":"3509_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhortra","year":"1997","unstructured":"Malhortra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141\u2013150","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0893-133X(89)90035-3","volume":"2","author":"RS Mansbach","year":"1989","unstructured":"Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299\u2013308","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0091-3057(01)00561-5","volume":"69","author":"RS Mansbach","year":"2001","unstructured":"Mansbach RS, Carver J, Zorn SH (2001) Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. Pharmacol Biochem Behav 69:535\u2013542","journal-title":"Pharmacol Biochem Behav"},{"key":"3509_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.euroneuro.2010.06.003","volume":"21","author":"SL McLean","year":"2011","unstructured":"McLean SL, Grayson B, Idris NF, Lesage AS, Pemberton D et al (2011) Activation of \u03b17 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia. Eur Neuropsychopharmacol 21:333\u2013343","journal-title":"Eur Neuropsychopharmacol"},{"key":"3509_CR56","first-page":"S170","volume":"37","author":"HY Meltzer","year":"2011","unstructured":"Meltzer HY, Gawryl M, Ward S, Dgetluck N, Bhuvaneswaran C, Koenig G et al (2011) EVP-6124, an alpha-7 nicotinic partial agonist, produces positive effects on cognition, clinical function, and negative symptoms in patients with chronic schizophrenia on stable antipsychotic therapy. Neuropsychopharmacology 37:S170","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","volume":"128","author":"JC Neill","year":"2010","unstructured":"Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL et al (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128:419\u2013432","journal-title":"Pharmacol Ther"},{"key":"3509_CR58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00213-013-3064-2","volume":"228","author":"M Noroozian","year":"2013","unstructured":"Noroozian M, Ghasemi S, Hosseini SM, Modabbernia A, Khodaie-Ardakani MR et al (2013) A placebocontrolled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia. Psychophramacology 228:595\u2013602","journal-title":"Psychophramacology"},{"key":"3509_CR59","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","volume":"63","author":"A Olincy","year":"2006","unstructured":"Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D et al (2006) Proof of concept trial of an \u03b17 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63:630\u2013638","journal-title":"Arch Gen Psychiatry"},{"key":"3509_CR60","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","volume":"33","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. J Psychiat Res 33:523\u2013533","journal-title":"J Psychiat Res"},{"key":"3509_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.npp.1301188","volume":"32","author":"P Pichat","year":"2007","unstructured":"Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, Santucci V et al (2007) SSR180711, a novel selective \u03b17 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32:17\u201334","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR62","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","volume":"62","author":"J Prickaerts","year":"2012","unstructured":"Prickaerts J, Van Goethem NP, Chesworth R, Shapiro G, Boess FG, Methfessel C et al (2012) EVP-6124, a novel and selective \u03b17 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of \u03b17 nicotinic acetylcholine receptors. Neuropharmacology 62:1099\u20131110","journal-title":"Neuropharmacology"},{"key":"3509_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.schres.2009.07.006","volume":"114","author":"RA Rabin","year":"2009","unstructured":"Rabin RA, Sacco KA, George TP (2009) Correlation of prepulse inhibition and Wisconsin card sorting test in schizophrenia and controls: effects of smoking status. Schizophr Res 114:91\u201397","journal-title":"Schizophr Res"},{"key":"3509_CR64","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1749-6632.1999.tb11332.x","volume":"30","author":"KA Radcliffe","year":"1999","unstructured":"Radcliffe KA, Fisher JL, Gray R, Dani JA (1999) Nicotinic modulation of glutamate and GABA synaptic transmission in hippocampal neurons. Ann N Y Acad Sci 30:591\u2013610","journal-title":"Ann N Y Acad Sci"},{"key":"3509_CR65","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1124\/jpet.112.197970","volume":"343","author":"RJ Radek","year":"2012","unstructured":"Radek RJ, Robb HM, Stevens KE, Gopalakrishnan M, Biner RS (2012) Effects of the novel \u03b17 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA\/2 mice: pharmacodynamic characterization. J Pharmacol Exp Ther 343:736\u2013745","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biopsych.2008.04.011","volume":"64","author":"C Ranganath","year":"2008","unstructured":"Ranganath C, Minzenberg MJ, Ragland JD (2008) The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry 64:18\u201325","journal-title":"Biol Psychiatry"},{"key":"3509_CR67","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1037\/0735-7044.111.4.667","volume":"111","author":"JM Reed","year":"1997","unstructured":"Reed JM, Squire LR (1997) Impaired recognition memory in patients with lesions limited to the hippocampal formation. Behav Neurosci 111:667\u2013675","journal-title":"Behav Neurosci"},{"key":"3509_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pnpbp.2008.11.018","volume":"33","author":"AH Rezvani","year":"2009","unstructured":"Rezvani AH, Kholdebarin E, Brucato FH, Callahan PM, Lowe DA, Levin ED (2009) Effect of R3487\/MEM3454, a novel nicotinic \u03b17 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. Prog Neuropsychopharmacol Biol Psychiatry 33:269\u2013275","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3509_CR69","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","volume":"21","author":"JS Rodefer","year":"2005","unstructured":"Rodefer JS, Murphy ER, Baxter MG (2005) PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur J Neurosci 21:1070\u20131076","journal-title":"Eur J Neurosci"},{"key":"3509_CR70","unstructured":"Rodefer JS, Baseile JL, Callahan PM, Van Natta K, Yeo H, Lowe DA et al (2007) Attentional set-shifting in rats and monkeys: effects of cholinergic challenges. Soc Neurosci Abstr p746.4"},{"key":"3509_CR71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/jpet.108.150094","volume":"329","author":"R Roncarati","year":"2009","unstructured":"Roncarati R, Scali C, Comery TA, Grauer SM, Aschmi S, Bothmann H et al (2009) Procognitive and neuroprotective activity of a novel \u03b17 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders. J Pharmacol Exp Ther 329:459\u2013468","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR72","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2:e141","journal-title":"PLoS Med"},{"key":"3509_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1744-859X-9-27","volume":"9","author":"A Shiina","year":"2010","unstructured":"Shiina A, Shirayama Y, Niitsu T, Hashimoto T, Yoshida T, Hasegawa T et al (2010) A randomized, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Ann Gen Psychiatry 9:27","journal-title":"Ann Gen Psychiatry"},{"key":"3509_CR74","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.bmcl.2012.03.062","volume":"22","author":"J Skidmore","year":"2012","unstructured":"Skidmore J, Atcha Z, Boucherat E, Castelletti L, Chen DW, Coppo FT et al (2012) The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement. Bioorg Med Chem Lett 22:3531\u20133534","journal-title":"Bioorg Med Chem Lett"},{"key":"3509_CR75","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev.neuro.27.070203.144130","volume":"27","author":"LR Squire","year":"2004","unstructured":"Squire LR, Stark CE, Clark RE (2004) The medial temporal lobe. Ann Rev Neurosci 27:279\u2013283","journal-title":"Ann Rev Neurosci"},{"key":"3509_CR76","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s002130050573","volume":"136","author":"KE Stevens","year":"1998","unstructured":"Stevens KE, Kem WR, Mahnir VM, Freedman R (1998) Selective \u03b17-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology 136:320\u2013327","journal-title":"Psychopharmacology"},{"key":"3509_CR77","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nm.2670","volume":"18","author":"PF Sullivan","year":"2012","unstructured":"Sullivan PF (2012) Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat Med 18:210\u2013211","journal-title":"Nat Med"},{"key":"3509_CR78","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s002130100799","volume":"56","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 56:194\u2013215","journal-title":"Psychopharmacology"},{"key":"3509_CR79","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/archpsyc.63.12.1325","volume":"63","author":"NR Swerdlow","year":"2006","unstructured":"Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL (2006) Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 63:1325\u20131335","journal-title":"Arch Gen Psychiatry"},{"key":"3509_CR80","first-page":"1","volume":"7","author":"MA Synder","year":"2013","unstructured":"Synder MA, Gao WJ (2013) NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front Cell Neurosci 7:1\u201312","journal-title":"Front Cell Neurosci"},{"key":"3509_CR81","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1124\/jpet.105.099218","volume":"318","author":"AV Terry Jr","year":"2006","unstructured":"Terry AV Jr, Parikh V, Gearhart DA, Pilai A, Hohnadel E et al (2006) Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. J Pharmacol Exp Ther 318:709\u2013724","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR82","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.neuroscience.2007.03.003","volume":"146","author":"AV Terry Jr","year":"2007","unstructured":"Terry AV Jr, Gearhart DA, Warner SE, Zhang G, Bartlett MG, Middlemore ML et al (2007) Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholingeric neurons, and memory performance. Neuroscience 146:1316\u20131332","journal-title":"Neuroscience"},{"key":"3509_CR83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuroscience.2011.08.038","volume":"195","author":"OA Timofeeva","year":"2011","unstructured":"Timofeeva OA, Levin ED (2011) Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia. Neuroscience 195:21\u201336","journal-title":"Neuroscience"},{"key":"3509_CR84","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/archpsyc.60.12.1193","volume":"60","author":"BI Turetsky","year":"2003","unstructured":"Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE (2003) Decrements in volume of anterior ventromedical temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry 60:1193\u20131200","journal-title":"Arch Gen Psychiatry"},{"key":"3509_CR85","first-page":"S187","volume":"35","author":"DMS Umbricht","year":"2009","unstructured":"Umbricht DMS, Lowe D, Yoo K, Porter R, Garibaldi G, Santarelli L et al (2009) The effect of the partial nicotinic alpha7 receptor agonist R3487 on cognitive deficits in schizophrenia. Neuropsychopharmacology 35:S187","journal-title":"Neuropsychopharmacology"},{"key":"3509_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1517\/14728222.2013.736498","volume":"17","author":"TL Wallace","year":"2013","unstructured":"Wallace TL, Bertrand D (2013) Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia. Expert Opin Ther Targets 17:139\u2013155","journal-title":"Expert Opin Ther Targets"},{"key":"3509_CR87","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bcp.2011.06.034","volume":"82","author":"TL Wallace","year":"2011","unstructured":"Wallace TL, Porter RHP (2011) Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition. Biochem Pharmacol 82:891\u2013903","journal-title":"Biochem Pharmacol"},{"key":"3509_CR88","unstructured":"Wallace TL, Chiu G, Dao H, Santarelli L, Porter R, Bertrand S, Bertrand D (2010) Modulation of cholinergic tone impacts the efficacy of RG3487\/MEM3454, a novel, nicotinic alpha 7 receptor agonist. Soc Neurosci Abstr p236.1"},{"key":"3509_CR89","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1124\/jpet.110.171892","volume":"336","author":"TL Wallace","year":"2011","unstructured":"Wallace TL, Callahan PM, Tehim A, Bertrand D, Tombaugh G, Wang S et al (2011) RG3487, a novel nicotinic \u03b17 receptor partial agonist, improves cognition and sensorimotor gating in rodents. J Pharmacol Exp Ther 336:242\u2013253","journal-title":"J Pharmacol Exp Ther"},{"key":"3509_CR90","unstructured":"Wallace-Boone TL, Chui G, Dao H, Lowe DA, Porter R, Santarelli L (2009) R3487\/MEM3454, a novel nicotinic alpha 7 receptor partial agonist, improves attention and working memory performance in cynomolgus macaques. Soc Neurosci Abstr p887"},{"key":"3509_CR91","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pharmthera.2009.02.004","volume":"122","author":"JW Young","year":"2009","unstructured":"Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA (2009) Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122:150\u2013202","journal-title":"Pharmacol Ther"},{"key":"3509_CR92","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1176\/appi.ajp.2012.11081289","volume":"169","author":"XY Zhang","year":"2012","unstructured":"Zhang XY, Liu L, Liu S, Hong X, Chen DC, Xiu MH et al (2012) Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. Am J Psychiatry 169:974\u2013981","journal-title":"Am J Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3509-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3509-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3509-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3509-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T22:36:38Z","timestamp":1689028598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3509-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,5]]},"references-count":92,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3509-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,5]]}}}